Search research articles
Contact Us
Filters
Showing results (1-10 of 223) with videos related to
Page
of 23
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
November 30, 2022
[Current Status of Formulary in Japan and the Assessment of Various Value Components of Medicines]
Ataru Igarashi
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
July 15, 2014
[Pharmacoeconomics of molecular targeting drugs]
Ataru Igarashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 17, 2023
[Life and Money? Life or Money? -Health Economic Assessment and Value Assessment for Oncology Medications]
Ataru Igarashi
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 30, 2022
Value assessment of new interventions for Alzheimer's disease dementia in Japan based on literature review and group interview
Ataru Igarashi, Shunya Ikeda
Journal of Medical Economics
|
January 21, 2022
Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan
Hiroaki Mamiya, Ataru Igarashi
Journal of Medical Economics
|
August 27, 2021
Determinants of market prices for drugs under Japan's national health insurance
Hiroaki Mamiya, Ataru Igarashi
Journal of Market Access & Health Policy
|
March 27, 2026
Updated Conversion Table for the Multiple Criteria Qualitative Value-Based Pricing Framework "MARIE"
Akina Takami, Ataru Igarashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 2016
[Universal Health Coverage and Cancer Drugs - A Cost-Effectiveness Perspective]
Ayako Fukuda, Ataru Igarashi
Journal of Medical Economics
|
October 22, 2024
Analysis of factors associated with premiums for reimbursed medical devices in Japan
Michael LoPresti, Ataru Igarashi
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 1, 2005
[Anti-rheumatoid biologics and pharmacoeconomic evaluation]
Kiichiro Tsutani, Ataru Igarashi
Page
of 23
Search research articles
Search
Showing results (1-10 of 223) with videos related to
Sort By:
Page
of 23
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
November 30, 2022
[Current Status of Formulary in Japan and the Assessment of Various Value Components of Medicines]
Ataru Igarashi
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
July 15, 2014
[Pharmacoeconomics of molecular targeting drugs]
Ataru Igarashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 17, 2023
[Life and Money? Life or Money? -Health Economic Assessment and Value Assessment for Oncology Medications]
Ataru Igarashi
Expert Review of Pharmacoeconomics & Outcomes Research
|
August 30, 2022
Value assessment of new interventions for Alzheimer's disease dementia in Japan based on literature review and group interview
Ataru Igarashi, Shunya Ikeda
Journal of Medical Economics
|
January 21, 2022
Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan
Hiroaki Mamiya, Ataru Igarashi
Journal of Medical Economics
|
August 27, 2021
Determinants of market prices for drugs under Japan's national health insurance
Hiroaki Mamiya, Ataru Igarashi
Journal of Market Access & Health Policy
|
March 27, 2026
Updated Conversion Table for the Multiple Criteria Qualitative Value-Based Pricing Framework "MARIE"
Akina Takami, Ataru Igarashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 2016
[Universal Health Coverage and Cancer Drugs - A Cost-Effectiveness Perspective]
Ayako Fukuda, Ataru Igarashi
Journal of Medical Economics
|
October 22, 2024
Analysis of factors associated with premiums for reimbursed medical devices in Japan
Michael LoPresti, Ataru Igarashi
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 1, 2005
[Anti-rheumatoid biologics and pharmacoeconomic evaluation]
Kiichiro Tsutani, Ataru Igarashi
Page
of 23